• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Psychiatry

Dog ownership may reduce loneliness and depression during the COVID-19 pandemic

byKiera LiblikandAvneesh Bhangu
April 10, 2022
in Psychiatry, Wellness
Reading Time: 2 mins read
Share on FacebookShare on Twitter

1. This observational study found that dog owners reported significantly lower social isolation and depression compared to non-dog owners.

2. However, anxiety and perceived happiness scores did not vary significantly between groups.

Evidence Rating Level: 2 (Good)

The coronavirus disease 2019 (COVID-19) pandemic has resulted in the implementation of public health measures limiting social interaction. Notably, loss of social support is a risk factor for decreased mental wellness. Dogs (Canis familiaris) are routinely used as a therapeutic aid to provide social support to patients in long-term and pediatric care. Accordingly, their companionship may reduce feelings of social isolation and associated mental health consequences during COVID-19.

This observational study aimed to delineate the impact of dog ownership on mental wellbeing during a global crisis, the COVID-19 pandemic. Participants were included who were >18 years of age, spoke English, were able to use a computer, and living in the United States. Individuals who owned an animal other than a dog were excluded from the study. Recruitment was conducted by a third-party research agency during November of 2020. Mental wellbeing was assessed with the Multidimensional Scale of Perceived Social Support (MSPSS), Center for Epidemiologic Studies Depression Scale-Revised (CESD-R), Generalized Anxiety Disorder Scale (GAD-7), and Oxford Happiness Questionnaire (OHQ).

In total, 1535 participants completed the survey with 768 in the dog owner group and 767 controls without pets. Dog owners reported significantly lower depression scores (p=0.018) than the control group as well as increased perceived social support (p=0.042). Alternatively, no significant difference was seen between groups in anxiety (p=0.186) and happiness scores (p=0216). However, the study results may not be generalizable as only individuals in the United States were recruited and may have been under different COVID-19 restrictions depending on their state of residence. Nonetheless, this study demonstrated that dog ownership may help mitigate the impact of emotional distress of social isolation.

RELATED REPORTS

The Scan by 2 Minute Medicine®: Sugary drinks track with higher depression risk while coffee shows the opposite, US measles cases reach their highest level in decades, peptide injections fuel the next wellness craze, and most routine blood tests do not require prolonged fasting

Video mental health care may have clinical advantages versus phone or in-person visits

Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms

Click to read the study in PLOS ONE

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: anxietydepressiondoglonelinessmental healthwellness
Previous Post

Wellness Check: Mental Health

Next Post

Daprodustat noninferior to darbepoetin alfa in the treatment of anemia in patients with chronic kidney disease on incident dialysis – the ASCEND-ID trial

RelatedReports

The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Sugary drinks track with higher depression risk while coffee shows the opposite, US measles cases reach their highest level in decades, peptide injections fuel the next wellness craze, and most routine blood tests do not require prolonged fasting

October 6, 2026
Chronic Disease

Video mental health care may have clinical advantages versus phone or in-person visits

September 12, 2026
Artificial Intelligence

Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms

September 11, 2026
Artificial Intelligence

Universal Health Services acquisition of Talkspace connects virtual and inpatient behavioral care

September 9, 2026
Next Post
Being overweight and obese associated with increased incidence of chronic kidney disease

Daprodustat noninferior to darbepoetin alfa in the treatment of anemia in patients with chronic kidney disease on incident dialysis – the ASCEND-ID trial

#VisualAbstract: Adding four doses of rituximab did not significantly improve event-free survival over standard of care in acute lymphoblastic leukaemia

#VisualAbstract: Adding four doses of rituximab did not significantly improve event-free survival over standard of care in acute lymphoblastic leukaemia

Compliance-linked incentives increase infant immunizations rates in rural India

2 Minute Medicine Rewind April 11, 2022

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Dexmedetomidine (Precedex) may offer similar analgesic efficacy as remifentanil (Ultiva) with fewer adverse effects in adults undergoing sleeve gastrectomy
  • The Scan by 2 Minute Medicine®: Sugary drinks track with higher depression risk while coffee shows the opposite, US measles cases reach their highest level in decades, peptide injections fuel the next wellness craze, and most routine blood tests do not require prolonged fasting
  • Earlier menopause is associated with faster cognitive decline and greater late-life brain changes
License Content
Terms of Use | Disclaimer
Cookie Policy
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.